Publisher： Bentham Science Publishers
E-ISSN： 1873-4286|14|17|1678-1685
ISSN： 1381-6128
Source： Current Pharmaceutical Design, Vol.14, Iss.17, 2008-06, pp. : 1678-1685
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Hepatitis C virus (HCV) infection is characterized by a number of autoreactive manifestations, such as autoantibody production, cryoglobulinemia and thyroid disorders. We will analyse critically the mechanisms invoked, and partially documented, to explain such manifestations arising in genetically predisposed individuals exposed to HCV. In particular we will examine the available evidence implicating the virus in lowering the B cell activation threshold, in directly infecting lymphocytes and in inducing self-reactivity through a mechanism of molecular mimicry. We will then move to the HCV related clinical immunopathological manifestations, with a specific attention to the effects of antiviral treatment.
Related content
Access to resources
Recommend
The Role of HLA Promoters in Autoimmunity
Current Pharmaceutical Design, Vol. 12, Iss. 29, 2006-10 ,pp. :
A role for leptin in autoimmunity?
By O'Neill L.
Trends in Pharmacological Sciences, Vol. 22, Iss. 7, 2001-07 ,pp. :
The burden of autoimmunity in myelodysplastic syndromes
Hematological Oncology (Electronic), Vol. 36, Iss. 1, 2018-02 ,pp. :
Autoimmunity and Apoptosis - Therapeutic Implications
Current Medicinal Chemistry, Vol. 14, Iss. 29, 2007-12 ,pp. :